Biotest AG (ETR:BIO)

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 5 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years 5 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 5 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 8 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 9 months ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 9 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 9 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 2 years 10 months ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 2 years 10 months ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 2 years 10 months ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Published on 08/04/2026 at 12:00, 37 minutes ago

Golden Minerals Announces Formation of Sand Canyon Joint Venture
Published on 08/04/2026 at 12:00, 37 minutes ago

Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System
Published on 08/04/2026 at 09:10, 3 hours 27 minutes ago

HM Exploration Drills 18.45 Metres of 1.14% Cu, 2.42 % Zn, 16.74 g/t Ag and 0.32 g/t Au in Upper Lens; 5.42m of 1.99% Cu, 1.66% Zn, 15.39g/t Ag and 0.8g/t Au in Lower lens at Lewis Pilley's
Published on 08/04/2026 at 09:05, 3 hours 32 minutes ago

BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
Published on 08/03/2026 at 23:00, 13 hours 37 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Financial Results

View all ACCESSWIRE

Published on 08/04/2026 at 12:02, 34 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 08/04/2026 at 12:00, 37 minutes ago

Verve Wins 2026 ADWEEK Tech Stack Award for Mobile Product/Platform
Published on 08/04/2026 at 11:45, 52 minutes ago

2026 World Manufacturing Convention Releases Teaser, Extending a Global Invitation to Innovate Together
Published on 08/04/2026 at 11:42, 55 minutes ago

Edison Group reaches global audience of over 8.5 million
Published on 08/04/2026 at 11:20, 1 hour 17 minutes ago

Indusface Introduces SwyftComply AI, Defining the Next Era of Application Security with Autonomous Vulnerability Remediation

View all EQS

Published on 08/04/2026 at 08:15, 4 hours 22 minutes ago

Covivio - Conditions of availability of the 2026 Half-year report
Published on 08/03/2026 at 18:45, 17 hours 52 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:00, 18 hours 37 minutes ago

H1 2026 revenue
Published on 08/03/2026 at 17:45, 18 hours 52 minutes ago

Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:45, 18 hours 52 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News